BOSTON and LAUSANNE, Switzerland, March 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong will participate in a fireside chat at the Barclays Global Healthcare Conference on Wednesday, March 16 at 11:15 a.m. ET/5:15 p.m. CET at the Loews Miami Beach Hotel in Miami, FL, United States.
A live webcast and replay of the session will be available on the investor relations section of the SOPHiA GENETICS website at https://ir.sophiagenetics.com .
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 790 hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM , or connect on Twitter , LinkedIn and Instagram . Where others see data, we see answers.
Investor Contact:
Jennifer Pottage
Head of Investor Relations
Jpottage@sophiagenetics.com
Media Contact:
Eliza Bamonti
Director of Public Relations
Ebamonti@sophiagenetics.com